Literature DB >> 23257913

G9a, a multipotent regulator of gene expression.

Shilpa Rani Shankar1, Avinash G Bahirvani, Vinay Kumar Rao, Narendra Bharathy, Jin Rong Ow, Reshma Taneja.   

Abstract

Lysine methylation of histone and non-histone substrates by the methyltransferase G9a is mostly associated with transcriptional repression. Recent studies, however, have highlighted its role as an activator of gene expression through mechanisms that are independent of its methyltransferase activity. Here we review the growing repertoire of molecular mechanisms and substrates through which G9a regulates gene expression. We also discuss emerging evidence for its wide-ranging functions in development, pluripotency, cellular differentiation and cell cycle regulation that underscore the complexity of its functions. The deregulated expression of G9a in cancers and other human pathologies suggests that it may be a viable therapeutic target in various diseases.

Entities:  

Keywords:  cancer; chromatin modifier; differentiation; gene expression; histones; methylation; transcription; transcription factors

Mesh:

Substances:

Year:  2012        PMID: 23257913      PMCID: PMC3549875          DOI: 10.4161/epi.23331

Source DB:  PubMed          Journal:  Epigenetics        ISSN: 1559-2294            Impact factor:   4.528


  68 in total

1.  Isolation and characterization of Suv39h2, a second histone H3 methyltransferase gene that displays testis-specific expression.

Authors:  D O'Carroll; H Scherthan; A H Peters; S Opravil; A R Haynes; G Laible; S Rea; M Schmid; A Lebersorger; M Jerratsch; L Sattler; M G Mattei; P Denny; S D Brown; D Schweizer; T Jenuwein
Journal:  Mol Cell Biol       Date:  2000-12       Impact factor: 4.272

2.  A histone H3 methyltransferase controls DNA methylation in Neurospora crassa.

Authors:  H Tamaru; E U Selker
Journal:  Nature       Date:  2001-11-15       Impact factor: 49.962

3.  Set domain-containing protein, G9a, is a novel lysine-preferring mammalian histone methyltransferase with hyperactivity and specific selectivity to lysines 9 and 27 of histone H3.

Authors:  M Tachibana; K Sugimoto; T Fukushima; Y Shinkai
Journal:  J Biol Chem       Date:  2001-04-20       Impact factor: 5.157

4.  Lack of somatic mutation in the coding sequence of SIAH1 in tumors hemizygous for this candidate tumor suppressor gene.

Authors:  M Medhioub; C Vaury; R Hamelin; G Thomas
Journal:  Int J Cancer       Date:  2000-09-15       Impact factor: 7.396

5.  Regulation of chromatin structure by site-specific histone H3 methyltransferases.

Authors:  S Rea; F Eisenhaber; D O'Carroll; B D Strahl; Z W Sun; M Schmid; S Opravil; K Mechtler; C P Ponting; C D Allis; T Jenuwein
Journal:  Nature       Date:  2000-08-10       Impact factor: 49.962

6.  Novel NG36/G9a gene products encoded within the human and mouse MHC class III regions.

Authors:  S E Brown; R D Campbell; C M Sanderson
Journal:  Mamm Genome       Date:  2001-12       Impact factor: 2.957

7.  G9a functions as a molecular scaffold for assembly of transcriptional coactivators on a subset of glucocorticoid receptor target genes.

Authors:  Danielle Bittencourt; Dai-Ying Wu; Kwang Won Jeong; Daniel S Gerke; Laurie Herviou; Irina Ianculescu; Rajas Chodankar; Kimberly D Siegmund; Michael R Stallcup
Journal:  Proc Natl Acad Sci U S A       Date:  2012-11-14       Impact factor: 11.205

8.  Histone H3K9 methyltransferase G9a represses PPARγ expression and adipogenesis.

Authors:  Lifeng Wang; Shiliyang Xu; Ji-Eun Lee; Anne Baldridge; Sean Grullon; Weiqun Peng; Kai Ge
Journal:  EMBO J       Date:  2012-11-23       Impact factor: 11.598

9.  Methylation muscles into transcription factor silencing.

Authors:  Narendra Bharathy; Reshma Taneja
Journal:  Transcription       Date:  2012-09-01

10.  G9a mediates Sharp-1-dependent inhibition of skeletal muscle differentiation.

Authors:  Belinda Mei Tze Ling; Suma Gopinadhan; Wai Kay Kok; Shilpa Rani Shankar; Pooja Gopal; Narendra Bharathy; Yaju Wang; Reshma Taneja
Journal:  Mol Biol Cell       Date:  2012-10-19       Impact factor: 4.138

View more
  69 in total

1.  A Role for Widely Interspaced Zinc Finger (WIZ) in Retention of the G9a Methyltransferase on Chromatin.

Authors:  Jeremy M Simon; Joel S Parker; Feng Liu; Scott B Rothbart; Slimane Ait-Si-Ali; Brian D Strahl; Jian Jin; Ian J Davis; Amber L Mosley; Samantha G Pattenden
Journal:  J Biol Chem       Date:  2015-09-03       Impact factor: 5.157

2.  EHMT1 and EHMT2 inhibition induces fetal hemoglobin expression.

Authors:  Aline Renneville; Peter Van Galen; Matthew C Canver; Marie McConkey; John M Krill-Burger; David M Dorfman; Edward B Holson; Bradley E Bernstein; Stuart H Orkin; Daniel E Bauer; Benjamin L Ebert
Journal:  Blood       Date:  2015-08-28       Impact factor: 22.113

3.  A post-translational modification switch controls coactivator function of histone methyltransferases G9a and GLP.

Authors:  Coralie Poulard; Danielle Bittencourt; Dai-Ying Wu; Yixin Hu; Daniel S Gerke; Michael R Stallcup
Journal:  EMBO Rep       Date:  2017-06-14       Impact factor: 8.807

4.  Inhibition of G9a methyltransferase stimulates fetal hemoglobin production by facilitating LCR/γ-globin looping.

Authors:  Ivan Krivega; Colleen Byrnes; Jaira F de Vasconcellos; Y Terry Lee; Megha Kaushal; Ann Dean; Jeffery L Miller
Journal:  Blood       Date:  2015-05-15       Impact factor: 22.113

5.  Functional Proteomic Analysis of Repressive Histone Methyltransferase Complexes Reveals ZNF518B as a G9A Regulator.

Authors:  Verena K Maier; Caitlin M Feeney; Jordan E Taylor; Amanda L Creech; Jana W Qiao; Attila Szanto; Partha P Das; Nicholas Chevrier; Catherine Cifuentes-Rojas; Stuart H Orkin; Steven A Carr; Jacob D Jaffe; Philipp Mertins; Jeannie T Lee
Journal:  Mol Cell Proteomics       Date:  2015-02-13       Impact factor: 5.911

Review 6.  A drive in SUVs: From development to disease.

Authors:  Vinay Kumar Rao; Ananya Pal; Reshma Taneja
Journal:  Epigenetics       Date:  2017-01-20       Impact factor: 4.528

7.  H3K9MTase G9a is essential for the differentiation and growth of tenocytes in vitro.

Authors:  Satoshi Wada; Hisashi Ideno; Akemi Shimada; Taichi Kamiunten; Yoshiki Nakamura; Kazuhisa Nakashima; Hiroshi Kimura; Yoichi Shinkai; Makoto Tachibana; Akira Nifuji
Journal:  Histochem Cell Biol       Date:  2015-03-27       Impact factor: 4.304

8.  G9a/RelB regulates self-renewal and function of colon-cancer-initiating cells by silencing Let-7b and activating the K-RAS/β-catenin pathway.

Authors:  Shih-Ting Cha; Ching-Ting Tan; Cheng-Chi Chang; Chia-Yu Chu; Wei-Jiunn Lee; Been-Zen Lin; Ming-Tsan Lin; Min-Liang Kuo
Journal:  Nat Cell Biol       Date:  2016-08-15       Impact factor: 28.824

Review 9.  Targeting the cancer epigenome for therapy.

Authors:  Peter A Jones; Jean-Pierre J Issa; Stephen Baylin
Journal:  Nat Rev Genet       Date:  2016-09-15       Impact factor: 53.242

10.  MeCP2 repression of G9a in regulation of pain and morphine reward.

Authors:  Zhi Zhang; Wenjuan Tao; Yuan-Yuan Hou; Wei Wang; Paul J Kenny; Zhizhong Z Pan
Journal:  J Neurosci       Date:  2014-07-02       Impact factor: 6.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.